479225-16-6

Usage

Uses

Used in Pharmaceutical Industry:
6-(3,4-Dimethoxyphenyl)-picolinic acid is utilized as a potential pharmaceutical agent due to its possible biological activity. 6-(3,4-Dimethoxyphenyl)-picolinic acid is under investigation for its potential role in drug development, with ongoing research aimed at understanding its precise properties and therapeutic applications.
Given the compound's current stage of study, specific applications and reasons for its use in the pharmaceutical industry are still being explored. 6-(3,4-Dimethoxyphenyl)-picolinic acid's unique structure with a 3,4-dimethoxyphenyl group may offer novel avenues for targeting various biological pathways or diseases, making it a promising candidate for future pharmaceutical research and development.

Upstream product

• 1267666-27-2 methyl 6-(3,4-dimethoxyphenyl)pyridine-2-carboxylate 
• 21190-87-4 6-bromo-pyridine-2-carboxylic acid 
• 122775-35-3 3,4-Dimethoxyphenylboronic acid 

Downstream Products

• 479222-52-1 1-(5-chlorothiazol-2-yl)-4-[(6-3,4-dimethoxyphenyl)pyridine-2-carbonyl]piperazine 
• 479222-44-1 1-[6-(3,4-dimethoxyphenyl)pyridine-2-carbonyl]-4-(4-methoxyphenyl)piperazine 
• 1267666-64-7 C₂₀H₂₅N₃O₃ 

Relevant academic research and scientific papers

Picolinamide compound and preparation method and application thereof

The invention discloses a picolinamide compound. The structural general formulas of the picolinamide compound are shown as formulas (I) and (II). The invention also discloses a preparation method of the picolinamide compound and application of the picolinamide compound in preparation of anti-tumor drugs. The picolinamide compound can effectively inhibit a variety of tumor cells, including human breast cancer cells, human lung cancer cells, human liver cancer cells and the like, has good anti-tumor active substances and can be used for preparing the anti-tumor drugs.

HETEROCYCLIC DIAMINE COMPOUNDS AS LIGANDS OF THE MELANIN CONCENTRATING HORMONE RECEPTOR USEFUL FOR THE TREATMENT OF OBESITY, DIABETES, EATING AND SEXUAL DISORDERS

Heterocyclic diamine compounds of formula (I) are provided. Such compounds may be used to modulate MCH receptor activity in vivo or in vitro, and are particularly useful in the treatment of a variety of metabolic, feeding and sexual disorders in humans, d

PHENYLPYRIDINE CARBONYL PIPERAZINE DERIVATIVE

The present invention relates to a compound which is represented by the following general formula and has type 4 phosphodiesterase inhibitory action, and uses and an intermediate compound thereof. (whereinR1, R2: hydrogen, a halogen, a lower alkyl, a lower alkoxy, or the like,R3, R4: hydrogen, a (substituted) lower alkyl, a halogen, or the like,R5: hydrogen, a lower alkyl, a lower alkoxycarbonyl, or the like, andn: 0 or 1).